Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

VTGNVTGN
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in VISTAGEN THERAPEUTICS INC

BANK OF AMERICA CORP /DE/ holds 16,570 shares of VTGN (VISTAGEN THERAPEUTICS INC), worth $3,745 as of 2026-Q2. This is a new position.

Current Value

$3,745

Current Shares

16,570

Total Value Change

-$58,621

Total Shares Change

-4,571

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
16,570
-
$3,7450.0%$0.23
21
2026-Q1
Exited
0
-100.0%
$00.0%$0.61
0
2025-Q4
Decreased
3,145
-90.9%
$2,0790.0%$0.68
0
2025-Q3
Increased
34,657
+926.0%
$123,0320.0%$3.54
24
2025-Q2
Increased
3,378
+399.0%
$6,7560.0%$1.97
18
2025-Q1
Decreased
677
-96.8%
$1,6920.0%$2.59
0
2024-Q4
New
21,141
-
$62,3660.0%$2.81
32

Other major holders of VTGN: Janus Henderson Group Ltd., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used